Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-28T00:24:15.380Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of Glycopeptides at a French Teaching Hospital

Published online by Cambridge University Press:  02 January 2015

A. M. Rogues ,
S. Guessous ,
H. Boulestreau ,
A. Lashéras ,
J. P. Gachie ,
V. Marque  and
J. P. Dosque
A. M. Rogues
Affiliation:
Service d'Hygiène Hospitalière, Bordeaux, France
S. Guessous
Affiliation:
Service d'Hygiène Hospitalière, Bordeaux, France
H. Boulestreau
Affiliation:
Service d'Hygiène Hospitalière, Bordeaux, France
A. Lashéras
Affiliation:
Service d'Hygiène Hospitalière, Bordeaux, France
J. P. Gachie
Affiliation:
Service d'Hygiène Hospitalière, Bordeaux, France
V. Marque
Affiliation:
Pharmacie, Groupe Hospitalier Pellegrin, Bordeaux, France
J. P. Dosque
Affiliation:
Pharmacie, Groupe Hospitalier Pellegrin, Bordeaux, France
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 24 , Issue 9 , September 2003 , pp. 638 - 639
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2003

References

1.Smith, TL, Pearson, ML, Wilcox, KR, et al.Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999;340:493–501.Google Scholar
2.Ploy, MC, Grelaud, C, Martin, C, de Lumley, L, Denis, F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 1998;351:1212.Google Scholar
3.Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995,16:105–113.Google Scholar
4.Jarvis, WR. Epidemiology, appropriateness, and cost of vancomycin use. Clin Infect Dis 1998;26:1200–1203.CrossRefGoogle ScholarPubMed
5.Ena, J, Dick, J, Jones, R, Wenzel, R. The epidemiology of intravenous vancomycin usage in a university hospital: a 10-year study. JAMA 1993;269:598–602.Google Scholar
6.Watanakunakorn, C. Prescribing pattern of vancomycin in a community teaching hospital with low prevalence of vancomycin resistant enterococci. Infect Control Hosp Epidemiol 1996;17:767–769.Google Scholar
7.Evans, M, Kortas, KJ. Vancomycin use in a university medical center: comparison with Hospital Infection Control Practices Advisory Committee Guidelines. Infect Control Hosp Epidemiol 1996;17:356–359.Google Scholar
8.Singer, MV, Haft, R, Bariam, T, Aronson, M, Shafer, A, Sands, KE. Vancomycin control measures at a tertiary-care hospital: impact of interventions on volume and patterns of use. Infect Control Hosp Epidemiol 1998;19:248–253.Google Scholar
9.Roghmann, MC, Perdue, BE, Polish, L. Vancomycin use in a hospital with vancomycin restriction. Infect Control Hosp Epidemiol 1999;20:60–63.CrossRefGoogle Scholar
10.Floret, N, Thouverez, M, Thalamy, B, Estavoyer, JM, Talon, D. Evaluation of vancomycin use in a large university-affiliated hospital in eastern France in 1999. Pharm World Sci 2001;23:93–97.Google Scholar